Skip to main

PLx Pharma

PLXP is nowPLXPQ
PLXP logo
This stock has changed its ticker name. This happens for a variety of reason, including a corporate merger or simply a change in company name.
Learn More
Go to the new stock page

Frequently Asked Questions (FAQ)

The 52-week high for PLx Pharma stock is $0.70. The current PLx Pharma stock price $undefined is 100.00% below its 52-week high

No, the PLx Pharma stock does not pay dividends to its shareholders

The target price for PLx Pharma stock is $16.60 based on the average of what a group of analyst think PLx Pharma stock could be worth at a future date. This is not a prediction by Public.com

How to buy PLx Pharma stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in PLx Pharma stock

    Navigate to the Explore page. Then, type PLx Pharma into the search bar. When you see PLx Pharma stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased PLx Pharma stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

PLx Pharma Stock Earnings

The value each PLXP share was expected to gain vs. the value that each PLXP share actually gained.

PLx Pharma (PLXP) reported Q3 2022 earnings per share (EPS) of -$0.37, beating estimates of -$0.44 by 15.91%. In the same quarter last year, PLx Pharma's earnings per share (EPS) was -$0.37. PLx Pharma is expected to release next earnings on 11/10/2022, with an earnings per share (EPS) estimate of $0.

Buy PLx Pharma (PLXP) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.